Global Pain Management Drugs & Devices Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Pain Management Drugs & Devices market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pain Management Drugs & Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pain Management Drugs & Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pain Management Drugs & Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pain Management Drugs & Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pain Management Drugs & Devices include Abbott, Johnson & Johnson, Medtronic Inc., Eli Lilly & Co., Pfizer, Abbvie Inc., Purdue Pharmaceuticals Lp, Novartis International Ag and Hisamitsu Pharmaceutical Co. Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pain Management Drugs & Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pain Management Drugs & Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Pain Management Drugs & Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pain Management Drugs & Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pain Management Drugs & Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pain Management Drugs & Devices sales, projected growth trends, production technology, application and end-user industry.


Pain Management Drugs & Devices Segment by Company

Abbott
Johnson & Johnson
Medtronic Inc.
Eli Lilly & Co.
Pfizer
Abbvie Inc.
Purdue Pharmaceuticals Lp
Novartis International Ag
Hisamitsu Pharmaceutical Co. Inc.
Glaxosmithkline
Endo International
Djo Global Inc.
Astrazeneca Depomed Inc.

Pain Management Drugs & Devices Segment by Type

Pharmaceuticals
Devices

Pain Management Drugs & Devices Segment by Application

Cancer Pain
Obstetrical Pain
Musculoskeletal Pain
Migraine Headache Pain
Burn Pain
Neuropathic Pain
Dental/Facial Pain

Pain Management Drugs & Devices Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs & Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs & Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs & Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pain Management Drugs & Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Management Drugs & Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pain Management Drugs & Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pain Management Drugs & Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Pain Management Drugs & Devices Market Size, 2020 VS 2024 VS 2031
1.3 Global Pain Management Drugs & Devices Market Size Estimates and Forecasts (2020-2031)
1.4 Global Pain Management Drugs & Devices Sales Estimates and Forecasts (2020-2031)
1.5 Global Pain Management Drugs & Devices Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Pain Management Drugs & Devices Market Dynamics
2.1 Pain Management Drugs & Devices Industry Trends
2.2 Pain Management Drugs & Devices Industry Drivers
2.3 Pain Management Drugs & Devices Industry Opportunities and Challenges
2.4 Pain Management Drugs & Devices Industry Restraints
3 Pain Management Drugs & Devices Market by Manufacturers
3.1 Global Pain Management Drugs & Devices Revenue by Manufacturers (2020-2025)
3.2 Global Pain Management Drugs & Devices Sales by Manufacturers (2020-2025)
3.3 Global Pain Management Drugs & Devices Average Sales Price by Manufacturers (2020-2025)
3.4 Global Pain Management Drugs & Devices Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pain Management Drugs & Devices Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pain Management Drugs & Devices Manufacturers, Product Type & Application
3.7 Global Pain Management Drugs & Devices Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pain Management Drugs & Devices Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pain Management Drugs & Devices Players Market Share by Revenue in 2024
3.8.3 2024 Pain Management Drugs & Devices Tier 1, Tier 2, and Tier 3
4 Pain Management Drugs & Devices Market by Type
4.1 Pain Management Drugs & Devices Type Introduction
4.1.1 Pharmaceuticals
4.1.2 Devices
4.2 Global Pain Management Drugs & Devices Sales by Type
4.2.1 Global Pain Management Drugs & Devices Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pain Management Drugs & Devices Sales by Type (2020-2031)
4.2.3 Global Pain Management Drugs & Devices Sales Market Share by Type (2020-2031)
4.3 Global Pain Management Drugs & Devices Revenue by Type
4.3.1 Global Pain Management Drugs & Devices Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pain Management Drugs & Devices Revenue by Type (2020-2031)
4.3.3 Global Pain Management Drugs & Devices Revenue Market Share by Type (2020-2031)
5 Pain Management Drugs & Devices Market by Application
5.1 Pain Management Drugs & Devices Application Introduction
5.1.1 Cancer Pain
5.1.2 Obstetrical Pain
5.1.3 Musculoskeletal Pain
5.1.4 Migraine Headache Pain
5.1.5 Burn Pain
5.1.6 Neuropathic Pain
5.1.7 Dental/Facial Pain
5.2 Global Pain Management Drugs & Devices Sales by Application
5.2.1 Global Pain Management Drugs & Devices Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pain Management Drugs & Devices Sales by Application (2020-2031)
5.2.3 Global Pain Management Drugs & Devices Sales Market Share by Application (2020-2031)
5.3 Global Pain Management Drugs & Devices Revenue by Application
5.3.1 Global Pain Management Drugs & Devices Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pain Management Drugs & Devices Revenue by Application (2020-2031)
5.3.3 Global Pain Management Drugs & Devices Revenue Market Share by Application (2020-2031)
6 Global Pain Management Drugs & Devices Sales by Region
6.1 Global Pain Management Drugs & Devices Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pain Management Drugs & Devices Sales by Region (2020-2031)
6.2.1 Global Pain Management Drugs & Devices Sales by Region (2020-2025)
6.2.2 Global Pain Management Drugs & Devices Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pain Management Drugs & Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Pain Management Drugs & Devices Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Pain Management Drugs & Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Pain Management Drugs & Devices Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pain Management Drugs & Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Pain Management Drugs & Devices Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Pain Management Drugs & Devices Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Pain Management Drugs & Devices Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Pain Management Drugs & Devices Revenue by Region
7.1 Global Pain Management Drugs & Devices Revenue by Region
7.1.1 Global Pain Management Drugs & Devices Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Pain Management Drugs & Devices Revenue by Region (2020-2025)
7.1.3 Global Pain Management Drugs & Devices Revenue by Region (2026-2031)
7.1.4 Global Pain Management Drugs & Devices Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Pain Management Drugs & Devices Revenue (2020-2031)
7.2.2 North America Pain Management Drugs & Devices Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Pain Management Drugs & Devices Revenue (2020-2031)
7.3.2 Europe Pain Management Drugs & Devices Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pain Management Drugs & Devices Revenue (2020-2031)
7.4.2 Asia-Pacific Pain Management Drugs & Devices Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Pain Management Drugs & Devices Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Pain Management Drugs & Devices Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Abbott
8.1.1 Abbott Comapny Information
8.1.2 Abbott Business Overview
8.1.3 Abbott Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Abbott Pain Management Drugs & Devices Product Portfolio
8.1.5 Abbott Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Pain Management Drugs & Devices Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Medtronic Inc.
8.3.1 Medtronic Inc. Comapny Information
8.3.2 Medtronic Inc. Business Overview
8.3.3 Medtronic Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Medtronic Inc. Pain Management Drugs & Devices Product Portfolio
8.3.5 Medtronic Inc. Recent Developments
8.4 Eli Lilly & Co.
8.4.1 Eli Lilly & Co. Comapny Information
8.4.2 Eli Lilly & Co. Business Overview
8.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Product Portfolio
8.4.5 Eli Lilly & Co. Recent Developments
8.5 Pfizer
8.5.1 Pfizer Comapny Information
8.5.2 Pfizer Business Overview
8.5.3 Pfizer Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Pfizer Pain Management Drugs & Devices Product Portfolio
8.5.5 Pfizer Recent Developments
8.6 Abbvie Inc.
8.6.1 Abbvie Inc. Comapny Information
8.6.2 Abbvie Inc. Business Overview
8.6.3 Abbvie Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Abbvie Inc. Pain Management Drugs & Devices Product Portfolio
8.6.5 Abbvie Inc. Recent Developments
8.7 Purdue Pharmaceuticals Lp
8.7.1 Purdue Pharmaceuticals Lp Comapny Information
8.7.2 Purdue Pharmaceuticals Lp Business Overview
8.7.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product Portfolio
8.7.5 Purdue Pharmaceuticals Lp Recent Developments
8.8 Novartis International Ag
8.8.1 Novartis International Ag Comapny Information
8.8.2 Novartis International Ag Business Overview
8.8.3 Novartis International Ag Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Novartis International Ag Pain Management Drugs & Devices Product Portfolio
8.8.5 Novartis International Ag Recent Developments
8.9 Hisamitsu Pharmaceutical Co. Inc.
8.9.1 Hisamitsu Pharmaceutical Co. Inc. Comapny Information
8.9.2 Hisamitsu Pharmaceutical Co. Inc. Business Overview
8.9.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product Portfolio
8.9.5 Hisamitsu Pharmaceutical Co. Inc. Recent Developments
8.10 Glaxosmithkline
8.10.1 Glaxosmithkline Comapny Information
8.10.2 Glaxosmithkline Business Overview
8.10.3 Glaxosmithkline Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Glaxosmithkline Pain Management Drugs & Devices Product Portfolio
8.10.5 Glaxosmithkline Recent Developments
8.11 Endo International
8.11.1 Endo International Comapny Information
8.11.2 Endo International Business Overview
8.11.3 Endo International Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Endo International Pain Management Drugs & Devices Product Portfolio
8.11.5 Endo International Recent Developments
8.12 Djo Global Inc.
8.12.1 Djo Global Inc. Comapny Information
8.12.2 Djo Global Inc. Business Overview
8.12.3 Djo Global Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Djo Global Inc. Pain Management Drugs & Devices Product Portfolio
8.12.5 Djo Global Inc. Recent Developments
8.13 Astrazeneca Depomed Inc.
8.13.1 Astrazeneca Depomed Inc. Comapny Information
8.13.2 Astrazeneca Depomed Inc. Business Overview
8.13.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product Portfolio
8.13.5 Astrazeneca Depomed Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pain Management Drugs & Devices Value Chain Analysis
9.1.1 Pain Management Drugs & Devices Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pain Management Drugs & Devices Production Mode & Process
9.2 Pain Management Drugs & Devices Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pain Management Drugs & Devices Distributors
9.2.3 Pain Management Drugs & Devices Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings